Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2266 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2197 (97%) | |
Discontinuation Reports |
124 |
|
| To be discontinued: | 4 (3%) | |
| Discontinued: | 118 (95%) | |
| Reversed: | 2 (2%) | |
Late reports |
451 (19%) |
|
Overdue reports |
11 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 2MG | SOLUTION | Resolved | 2023-03-20 | 2023-04-13 | 187433 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 2MG | SOLUTION | Resolved | 2023-04-21 | 2023-05-09 | 190148 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 2MG | SOLUTION | Resolved | 2023-08-29 | 2023-08-30 | 203181 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 2MG | SOLUTION | Resolved | 2024-01-08 | 2024-02-01 | 215339 |
| HYOSCINE BUTYLBROMIDE INJECTION | 20MG | SOLUTION | Resolved | 2022-08-18 | 2022-12-14 | 167324 |
| IMIPENEM AND CILASTATIN FOR INJECTION USP | 500MG 500MG | POWDER FOR SOLUTION | Resolved | 2021-08-09 | 2021-08-16 | 143854 |
| IMIPENEM AND CILASTATIN FOR INJECTION USP | 250MG 250MG | POWDER FOR SOLUTION | Resolved | 2021-08-23 | 2023-10-27 | 144424 |
| INCLUNOX | 100MG | SOLUTION | Resolved | 2022-03-10 | 2022-10-22 | 156455 |
| INCLUNOX | 30MG | SOLUTION | Resolved | 2022-03-10 | 2022-09-10 | 156458 |
| INCLUNOX | 40MG | SOLUTION | Resolved | 2022-03-10 | 2022-09-10 | 156461 |
| INCLUNOX | 60MG | SOLUTION | Resolved | 2022-03-10 | 2022-10-22 | 156464 |
| INCLUNOX | 80MG | SOLUTION | Resolved | 2022-03-10 | 2022-10-22 | 156467 |
| INCLUNOX HP | 120MG | SOLUTION | Resolved | 2022-03-10 | 2022-10-22 | 156447 |
| INCLUNOX HP | 150MG | SOLUTION | Resolved | 2022-03-10 | 2022-05-21 | 156450 |
| ISOPROTERENOL HYDROCHLORIDE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2020-09-16 | 2022-03-11 | 124327 |
| ISOPROTERENOL HYDROCHLORIDE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-01-04 | 2023-03-07 | 179784 |
| ISOPROTERENOL HYDROCHLORIDE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2025-07-21 | 2025-08-05 | 263259 |
| KETAMINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2017-11-28 | 2017-12-15 | 31054 |
| KETAMINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2021-01-25 | 2021-02-09 | 132400 |
| KETAMINE HYDROCHLORIDE INJECTION USP | 50MG | SOLUTION | Resolved | 2021-11-15 | 2021-12-21 | 149292 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Discontinued | 2021-09-02 | 2021-09-02 | 145015 |
| VITAMIN B12 | 100MCG | LIQUID | Discontinued | 2017-06-06 | 2017-07-01 | 12133 |
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |